TY - JOUR
T1 - Analysis of intracorporeal compared with extracorporeal urinary diversion after robot-assisted radical cystectomy
T2 - Results from the international robotic cystectomy consortium
AU - Ahmed, Kamran
AU - Khan, Shahid A.
AU - Hayn, Matthew H.
AU - Agarwal, Piyush K.
AU - Badani, Ketan K.
AU - Derya Balbay, M.
AU - Castle, Erik P.
AU - Dasgupta, Prokar
AU - Ghavamian, Reza
AU - Guru, Khurshid A.
AU - Hemal, Ashok K.
AU - Hollenbeck, Brent K.
AU - Kibel, Adam S.
AU - Menon, Mani
AU - Mottrie, Alex
AU - Nepple, Kenneth
AU - Pattaras, John G.
AU - Peabody, James O.
AU - Poulakis, Vassilis
AU - Pruthi, Raj S.
AU - Redorta, Joan Palou
AU - Rha, Koon Ho
AU - Richstone, Lee
AU - Saar, Matthias
AU - Scherr, Douglas S.
AU - Siemer, Stefan
AU - Stoeckle, Michael
AU - Wallen, Eric M.
AU - Weizer, Alon Z.
AU - Wiklund, Peter
AU - Wilson, Timothy
AU - Woods, Michael
AU - Khan, Muhammad Shamim
PY - 2014/2
Y1 - 2014/2
N2 - Background Intracorporeal urinary diversion (ICUD) has the potential benefits of a smaller incision, reduced pain, decreased bowel exposure, and reduced risk of fluid imbalance. Objective To compare the perioperative outcomes of patients undergoing extracorporeal urinary diversion (ECUD) and ICUD following robot-assisted radical cystectomy (RARC). Design, setting, and participants We reviewed the database of the International Robotic Cystectomy Consortium (IRCC) (18 international centers), with 935 patients who had undergone RARC and pelvic lymph node dissection (PLND) between 2003 and 2011. Intervention All patients within the IRCC underwent RARC and PLND as indicated. The urinary diversion was performed either intracorporeally or extracorporeally. Outcome measurements and statistical analysis Demographic data, perioperative outcomes, and complications in patients undergoing ICUD or ECUD were compared. All patients had at least a 90-d follow-up. The Fisher exact test was used to summarize categorical variables and the Wilcoxon rank sum test or Kruskal-Wallis test for continuous variables. Results and limitations Of 935 patients who had RARC and PLND, 167 patients underwent ICUD (ileal conduit: 106; neobladder: 61), and 768 patients had an ECUD (ileal conduit: 570; neobladder: 198). Postoperative complications data were available for 817 patients, with a minimum follow-up of 90 d. There was no difference in age, gender, body mass index, American Society of Anesthesiologists grade, or rate of prior abdominal surgery between the groups. The operative time was equivalent (414 min), with the median hospital stay being marginally longer for the ICUD group (9 d vs 8 d, p = 0.086). No difference in the reoperation rates at 30 d was noted between the groups. The 90-d complication rate was not significant between the two groups, but a trend favoring ICUD over ECUD was noted (41% vs 49%, p = 0.05). Gastrointestinal complications were significantly lower in the ICUD group (p ≤ 0.001). Patients with ICUD were at a lower risk of experiencing a postoperative complication at 90 d (32%) (odds ratio: 0.68; 95% confidence interval, 0.50-0.94; p = 0.02). Being a retrospective study was the main limitation. Conclusions Robot-assisted ICUD can be accomplished safely, with comparable outcomes to open urinary diversion. In this cohort, patients undergoing ICUD had a relatively lower risk of complications.
AB - Background Intracorporeal urinary diversion (ICUD) has the potential benefits of a smaller incision, reduced pain, decreased bowel exposure, and reduced risk of fluid imbalance. Objective To compare the perioperative outcomes of patients undergoing extracorporeal urinary diversion (ECUD) and ICUD following robot-assisted radical cystectomy (RARC). Design, setting, and participants We reviewed the database of the International Robotic Cystectomy Consortium (IRCC) (18 international centers), with 935 patients who had undergone RARC and pelvic lymph node dissection (PLND) between 2003 and 2011. Intervention All patients within the IRCC underwent RARC and PLND as indicated. The urinary diversion was performed either intracorporeally or extracorporeally. Outcome measurements and statistical analysis Demographic data, perioperative outcomes, and complications in patients undergoing ICUD or ECUD were compared. All patients had at least a 90-d follow-up. The Fisher exact test was used to summarize categorical variables and the Wilcoxon rank sum test or Kruskal-Wallis test for continuous variables. Results and limitations Of 935 patients who had RARC and PLND, 167 patients underwent ICUD (ileal conduit: 106; neobladder: 61), and 768 patients had an ECUD (ileal conduit: 570; neobladder: 198). Postoperative complications data were available for 817 patients, with a minimum follow-up of 90 d. There was no difference in age, gender, body mass index, American Society of Anesthesiologists grade, or rate of prior abdominal surgery between the groups. The operative time was equivalent (414 min), with the median hospital stay being marginally longer for the ICUD group (9 d vs 8 d, p = 0.086). No difference in the reoperation rates at 30 d was noted between the groups. The 90-d complication rate was not significant between the two groups, but a trend favoring ICUD over ECUD was noted (41% vs 49%, p = 0.05). Gastrointestinal complications were significantly lower in the ICUD group (p ≤ 0.001). Patients with ICUD were at a lower risk of experiencing a postoperative complication at 90 d (32%) (odds ratio: 0.68; 95% confidence interval, 0.50-0.94; p = 0.02). Being a retrospective study was the main limitation. Conclusions Robot-assisted ICUD can be accomplished safely, with comparable outcomes to open urinary diversion. In this cohort, patients undergoing ICUD had a relatively lower risk of complications.
KW - Complications
KW - Extracorporeal urinary diversion
KW - Intracorporeal urinary diversion
KW - Outcomes
KW - Robot-assisted
KW - Robotic radical cystectomy
KW - Urinary diversion
UR - http://www.scopus.com/inward/record.url?scp=84891825025&partnerID=8YFLogxK
U2 - 10.1016/j.eururo.2013.09.042
DO - 10.1016/j.eururo.2013.09.042
M3 - Article
C2 - 24183419
AN - SCOPUS:84891825025
SN - 0302-2838
VL - 65
SP - 340
EP - 347
JO - European Urology
JF - European Urology
IS - 2
ER -